Long Acting Stimulant Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Young Children
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
This is a pilot study evaluating the effectiveness, safety, and tolerability of Ritalin LA in
treating Attention Deficit Hyperactivity Disorder (ADHD) in 4 and 5 year old children.
Virtually no data has been published on the use of long-acting stimulant preparations in very
young children despite early symptomatic development in a significant portion of young
children with ADHD. This would be one of the first studies looking at a long-acting
preparation of a stimulant medication in the treatment of ADHD in very young children.
Hypotheses
1. Ritalin LA is effective for the treatment of ADHD in 4 and 5 year old children.
2. Ritalin LA is reasonably well-tolerated in the treatment of ADHD in 4 and 5 year old
children.